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Abstract
Background: Spirometry reference values are important for the interpretation of spirometry results. Reference values should
be updated regularly, derived from a population as similar to the population for which they are to be used and span across
all ages. Such spirometry reference equations are currently lacking for central European populations.
Objective: To develop spirometry reference equations for central European populations between 8 and 90 years of age.
Materials:We used data collected between January 1993 and December 2010 from a central European population. The data
was modelled using ‘‘Generalized Additive Models for Location, Scale and Shape’’ (GAMLSS).
Results: The spirometry reference equations were derived from 118’891 individuals consisting of 60’624 (51%) females and
58’267 (49%) males. Altogether, there were 18’211 (15.3%) children under the age of 18 years.
Conclusion: We developed spirometry reference equations for a central European population between 8 and 90 years of
age that can be implemented in a wide range of clinical settings.
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Introduction
‘‘Spirometry measurements are important in diagnosis and
follow-up of patients with respiratory diseases and their interpre-
tation relies on the availability and use of appropriate reference
equations [1]. In Europe, the most commonly used reference
equations are outdated [2] and the continued publication of new
reference equations [3] reflects the widespread recognition of the
limitations of the existing ones. Most reference equations are
indeed inappropriate for central European populations as they
have either been derived from a small or non-European
population [3] or used statistical methods that cannot adequately
model the complexity of age-dependent lung function [2]’’.
Additionally, published reference values are mostly derived from
healthy never-smoking populations of restricted age ranges [3] and
should not be extrapolated beyond the published range [1,4,5].
Practically, however, clinicians often track disease progression over
long periods or assess effectiveness of therapy over time in patients
who are not ‘‘healthy never-smokers’’. There is, therefore, an
important need for practical reference values spanning across all
ages derived from a population most similar to that for which the
equations are to be used.
Such reference equations are statistically challenging as on the
one hand individual spirometry measurements are determined by
age, sex, height, health status, ethnicity, equipment and general
population characteristics (so called ‘‘cohort effect’’) [1,4,6] and
the European Respiratory Society (ERS)/American Thoracic
Society (ATS) recommend taking these characteristics into account
when developing and updating reference equations [1]. On the
other hand, the lung volume changes according to height and age
with a skewed distribution [7,8]. Statistical methods taking
multiple variables as well as this complex distribution into account
have been developed and compared [9] in recent years. A possible
approach that has been applied to spirometry data are General-
ized Additive Models for Location, Scale and Shape (GAMLSS)
methods. GAMLSS allows modelling of data with skewed and
kurtotic distribution and is therefore ideal for spirometry reference
equations including transition from childhood to adulthood
[10,11].
The aim of this study was to develop reference equations for a
central European Population between 8 and 90 year olds.
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Materials and Methods
In this study we used data collected by the ‘‘LuftiBus’’ which is a
project that has been described in detail previously [12,13].
Briefly, the ‘‘LuftiBus’’ is a mobile bus equipped with two flow-
sensing spirometers that tours the greater Zurich (Switzerland)
area and offers spirometry measurements to the general popula-
tion. Spirometry data were recorded electronically along with data
from a standardised interviewer-administered questionnaire col-
lecting basic information on health and lifestyle of the subjects.
Lung function tests were charged 10 CHF for adults and 5 CHF
for children if the bus was not leased by an organisation or a
community in which case the test was free of charge. When the bus
was leased by schools, entire classrooms were tested. In children,
weight (kg) and standing height (cm) were measured according to
WHO recommendations [14], in adults they were either asked or
measured.
Study Population
For this analysis we used the data collected from volunteers
between January 1993 and December 2010. In the course of the
years the ‘‘LuftiBus’’ visited each village of the Zurich County. In
each village a similar proportion of the population was tested. This
proportion ranged from 0.66% in Andelfingen to 2.05% in
Dielsdorf. Additionally, the age distribution of the ‘‘LuftiBus’’
dataset is similar to the age distribution of the Swiss population
with the exception for an over-representation of teenagers [15].
Although the population tested was mainly of Western European
descent, ethnicity was recorded as of 2004 (33.7% of the whole
population). Non-Western European descent participants account-
ed for 375 (2.04%) men and 355 (1.98%) women and were
excluded from the analysis. They were the only individuals
excluded from the dataset. The Zurich population is representative
of Central and Western European populations [16], or North-
West/Central European populations [17].
Spirometry
The ‘‘LuftiBus’’ is equipped with two computerised pneumo-
tachographs (SensorMedics1 Vmax Legacy 20c spirometer run by
Vision 7-2b software; VIASYS, Yorba Linda, CA, USA). The
volume signal of the equipment was calibrated at least once daily
with a 3-L syringe. Tests were performed in a sitting position
according to American Thoracic Society (ATS) guidelines until
end of 2005 and ATS/European Respiratory Society (ERS)
guidelines as of 2006 without nose-clips and after oral instruction
by the technician [18,19]. Participants were assisted by trained
spirometry technicians who performed immediate on-screen
evaluation of major acceptability criteria (including start, duration
and end of test) in addition to the automated review performed by
the computer software. As recommended by the ATS/ERS task
force [19] subjects were asked to perform up to a maximum of
eight manoeuvres in an attempt to obtain reproducible results.
The largest forced vital capacity (FVC) and forced expiratory
volume in one second (FEV1) were selected. All other parameters
[FEV1/FVC ratio, peak expiratory flow (PEF), mean expiratory
flow at 75%, 50%, 25% of expired volume (MEF75, 50, 25)] were
taken from the trial with the largest sum of FVC and FEV1.
Definition of variables
For the analysis we defined the two exploratory variables
‘‘smoking’’ and ‘‘sick’’. Smoking was defined as a cumulative self-
reported smoking history of more than one pack-year. A pack-year
being defined as years of smoking times the number of cigarettes
smoked per day divided by 20. For the exploratory variable
‘‘smoking’’ passive smokers were considered non-smokers. Sick
volunteers were defined as meeting one of the following criteria: i)
common cold at the time of the measurement or ii) lung disease at
the time of the measurement, which included acute bronchitis or
respiratory symptoms (cough, wheezing, phlegm, shortness of
breath during rest or exertion); asthma medication at the time of
the measurement; history of asthma; history of chronic obstructive
pulmonary disease; chronic bronchitis or a history of other lung
diseases (e.g. lung surgery, pulmonary embolism). Volunteers with
non-respiratory diseases such as diabetes or heart diseases were
included in the healthy group. For the analysis we defined 4 health
groups: healthy/non-smoker, healthy/smoker, sick/non-smoker
and sick/smoker.
Statistical analysis
Statistical analysis was performed with the statistical software
‘‘R’’ version 2.13.1 (R Development Core Team 2011) with the
packages ‘gamlss’ (version 4.0-8) and ‘gamlss.tr’ (version 4.0-4) for
the GAMLSS models [10,11,20] and with the package ‘quantreg’
(version 4.71) for the quantile regression models [21]. Within the
GAMLSS framework we used the four-parametric Box-Cox
power exponential density distribution function (BCPE(m, s, n,
t)) as this distribution allows modelling of the expectation (m), the
variance (s), the skewness (n) as well as the kurtosis (t) [10] and a
truncated BCPE distribution for FEV1/FVC as that endpoint
cannot exceed 100%. Due to the non-linear relation between the
spirometry parameters and age we used a bent hyperbola model
for the m link with two change points and two transition
smoothness parameters. Further, the non-linear relation between
the spirometry parameters and age for the s link was modelled by
fractional polynomials of the 2nd degree. The change points and
the transition smoothness parameters were estimated using the L-
BFGS-B algorithm and within the GAMLSS models framework
using the generalized Akaike’s information criteria (GAIC) with a
penalty of 3 and Bayesian Information Criterion (BIC). Contin-
uous variables are presented as median and inter-quartile range.
We modelled the relation between the spirometry parameters and
the covariates age, height, sex, smoking status and disease status.
Besides, several models with interaction terms formed of the
variables age, sex and height were fitted and selected using GAIC
with a penalty 3 and BIC.
Results
Study population
From a total of 128’568 measurements 9’677 were excluded due
to age (,8 years, .90 years) incomplete data or non-Western-
European origin. The spirometry reference equations were
derived from 118’891 individuals consisting of 60’624 (51%)
females and 58’267 (49%) males. In total there were 18’211
(15.3%) children under the age of 18 years. The age distribution of
the study population is shown in Figure 1. The main character-
istics of the study population can be taken from Table 1. In adults
58.9% of the women and 43.8% of the men were never smokers.
All together 34.9% of the individuals under the age of 18 were
either active (19.9%) or passive smokers (14.9%). Of all
individuals, 66.3% where healthy, 6.8% had a common cold at
the time of the measurement, 17.0% had a lung disease and 9.8%
a non lung-related disease such as diabetes or heart disease.
Reference equation modelled with GAMLSS
The lung function parameters FEV1, FVC, PEF, MEF25,
MEF50, MEF75 were modelled with the Box-Cox power
exponential density distribution function (BCPE(m, s, n, t)). A
Spirometry Reference Equations for All Ages
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truncated BCPE(m, s, n, t) function was used to model the lung
function parameter FEV1/FVC. The BCPE distribution was
necessary as it was not possible to renounce modelling the kurtosis
(when using e.g. the BCCG distribution) as this would worsen the
model fit and increases the BIC (GAIC) in the models for all
endpoints. Residual analyses based on worm plot were done in
order to identify model inadequacies and were performed
graphically for all models (Figures S1 and S2). A good model fit
was achieved as only about 1484 (1.21%) individuals were not on
the QQ-line. The BCPE(m, s, n, t) function gives a distribution
from which the 5th quantile can be predicted. This is the quantile
generally recommended for the lower limit of the normal range.
The reference values (5th quantile), according to the GAMLSS
model, can be calculated by the four functions in Table 2 and
transformed to z-scores as described by the formula 1 of reference
[10] (Figure S3).
Comparison between the four health groups
Our reference equations not only include information on age,
sex and height but also on health and smoking status. This allows
us to model the entire population and produce adaptable reference
equations, where smokers can be compared to a smoking
Figure 1. Age distribution of the reference population. A comparison with the age distribution of the Swiss population in 2011 is made.
doi:10.1371/journal.pone.0052619.g001
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population. To illustrate this concept, Figure 2 shows a graphical
representation of four different populations: ‘‘healthy/non-smok-
er’’ (54’488, 45.5%), ‘‘healthy/smoker’’ (36’760, 30.7%), ‘‘sick/
non-smoker’’ (17’127, 14.3%) and ‘‘sick/smoker’’ (11’391, 9.5%).
The biggest difference between these populations can be seen for
the 5th quantile which is generally used as the lower limit of
normal. Not surprisingly, the individuals with the highest
prediction values are the ‘‘healthy/non-smokers’’. The ‘‘sick’’
individuals have the lowest values. A mean difference of 0.33 litres
in men and 0.27 litres in women is seen between healthy/non-
smokers and sick/smokers.
Quantile Regression reference equation and comparison
with GAMLSS
As equations modelled with GAMLSS are complex and cannot
be implemented in every spirometer we developed reference
equations with quantile regression to increase the implementation
possibilities. However, residual analyses revealed a worse fit than
for the GAMLSS models for all endpoints (additional information
can be found in the supporting information online).
Sensitivity analysis
A sensitivity analysis was performed for the following variables:
Compulsory measurement in children. In 66.5% of all
children and adolescents spirometry was done in a compulsory
setting. No significant difference was seen when excluding children
measured in a volunteer setting.
Years of data collection. As the data was collected over a
period of 17 years we analysed a linear time trend but did not find
any significant difference over time.
Body Mass Index (BMI). Only marginal differences were
found when comparing the reference equations for BMI cut-of
values of ,25, 25–30 and .30 for adults and their equivalents for
children [22].
Common cold. Reference values for common cold alone
were only marginally different than reference values for healthy
individuals.
As only marginal differences were found in all sensitivity
analysis (data not shown) all individuals and years were included in
the final population.
Discussion
We developed spirometry reference equations for 8–90 year olds
from a very large, cross-sectional sample of a Central European
population.
‘‘Spirometry reference values are important for the interpreta-
tion of individual spirometry measurements and may influence
clinical decision making. Most published reference equations use
statistical methods that cannot adequately model the complexity of
age-dependent lung function [2] and very few span across all ages
[3] introducing discontinuities at the transition points with
potential clinical implications for individuals with chronic lung
diseases.’’
One exception are the recently published spirometry reference
equations by Stanojevic et al., developed with complex statistical
methods for individuals aged 4–80 years of age [8]. As their
reference equations were derived from 4 pooled datasets collected
in 4 different countries (USA, Canada, UK and Belgium) their
reference values can be generalized to other mixed populations
with similar ethnic backgrounds. The reference equations we
developed are complementary to theirs as they also span from
school age to old age and use similar statistical methods. However,
they are derived from a single Central European population with
homogenous local environmental factors and genetic background
and the data was collected using the same instruments and testing
procedures throughout the years. Nevertheless, both equations
result in similar values [8] (Figure 2: healthy non-smoker). In boys,
the peak lung function is reached at the age of 20 years with almost
4.5 l followed by an age-dependent decline to just under 2.75 l at
the age of 80 years. In girls, the peak lung function is reached at 19
years with 3.4 l followed by an age-dependent decline to 2 l at the
age of 80 years. The decline is initially less steep in the LuftiBus
population with 3.2 l at the age of 40 years compared to 3 l in the
Stanojevic reference equations.
Spirometry reference equations should be derived from a
population as similar to the population from which the patient
originates as possible [23]. However, most spirometry reference
equations are derived from healthy non-smoking individuals [3]
who are generally a small subsample and have higher reference
values than the general population [24]. Some authors have
therefore included smokers in their reference population when the
Table 1. Characteristics of the study population.
N=118’891 Female n=60’624 Male n=58’267
Adults Children (,18) Adults Children (,18)
52’245 (100%) 8’379 (100%) 48’435 (100%) 9’832 (100%)
Age 50 (25) 14 (3) 47 (27) 15 (3)
Smoking:
Never-Smokers 30’753 (58.9%) 5’664 (67.6%) 21’207 (43.8%) 6’169 (62.7%)
Smokers/Ex- Smokers 18’419 (35.3%) 1’436 (17.1%) 25’769 (53.2%) 2’208 (22.5%)
Passive smokers 3’073 (5.9%) 1’279 (15.3%) 1’459 (3.0%) 1’455 (14.8%)
Health status:
Healthy 33’256 (63.7%) 5’628 (67.2%) 33’211 (68,6%) 6’770 (68.9%)
Common cold 2’610 (5.0%) 1’134 (13.5%) 3’040 (6.3%) 1’263 (12.8%)
Lung diseases 9’745 (18.7%) 1’479 (17.7%) 7’378 (15.2%) 1’652 (16.8%)
Other diseases 6’634 (12.7%) 138 (1.6%) 4’806 (9.9%) 147 (1.5%)
For age we reported medians and inter-quartile range (in brackets) since the distribution was skewed.
Other diseases include all non-lung diseases such as diabetes, heart diseases, etc.
doi:10.1371/journal.pone.0052619.t001
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smoking prevalence was high [25]. The statistical methods we used
permitted us to model the entire population while including
information on smoking and health status. This allows clinicians to
choose which reference values are most appropriate for a given
individual. Indeed, although in most situations reference values for
healthy-never-smokers will be used, reference values for healthy-
smokers might be more appropriate for certain patients when
tracking disease progression or assessing effectiveness of therapy
over time. By including information on disease the reference
equations allow a comparison between healthy and sick individ-
uals. As can be seen in Figure 2 our data confirm that individuals
with lung diseases have lower spirometry values than healthy
individuals. Even though individuals with common cold where
included in the ‘‘sick’’ group, they did not have significantly
different reference values than healthy individuals, suggesting as
recently published [24] that not all respiratory symptoms need to
be accounted for when performing spirometry in patients.
Practically, the reference values according to the GAMLSS
model can be calculated by the four functions in Table 2 and the
formula found in Figure S3 [10]. To begin with, the values age,
sex, and height of a person have to be known. Smoker and sick are
for the clinician to decide. If the clinician would like to compare a
person to a ‘‘healthy-non-smoker’’ population then ‘‘smoker’’ and
‘‘sick’’ should be set to zero. The values calculated with the Table 2
must then be inserted in the function found in Figure S3 from
where the quantiles can be calculated. However, since these are
complex algebraic equations, the reference values are best
obtained by using the statistical software package R where the
function ‘qBCPE’ implemented in the package ‘gamlss’ can be
used. R is a free language and environment for statistical
computing and graphics that can be downloaded from the
following internet site (http://www.r-project.org/). Additionally,
upon request, the authors will gladly provide the source code in R,
thus facilitating its implementation in spirometry devices.
To allow the reference equations to be implemented in a wide
range of spirometers we additionally developed reference equa-
tions with quantile regression [12,26,27] using the same endpoints
(Table S1). A comparison between GAMLSS and quantile
regression models was done in Figure S5. However, compared
to the GAMLSS models, residual analyses revealed a worse model
fit for all endpoints (Figure S1, S4). Therefore, while the GAMLSS
reference equations should be used whenever possible as they give
the most accurate reference values the quantile regression
equations can be implemented as an alternative.
The reference equations for 18–80 years old recently published
by Kuster et al [12] are derived from the same data set. However,
the two reference equations are not directly comparable. Indeed,
we included data spanning from school age to old age thus
modelling the growth spurt of puberty and the transition from
childhood to adulthood. The equations presented herein therefore
expand and complement the reference equations from Kuster at
al.
The ATS/ERS task force recommends that reference values be
derived from a ‘‘representative sample of healthy subjects in a
general population’’; but, alternatively, can also be derived from a
‘‘large group of volunteers, provided that criteria for normal
selection and proper distribution of anthropometric characteristics
are satisfied’’ [1]. Although the population visiting the ‘‘LuftiBus’’
consisted mostly of volunteers and was thus possibly motivated by
personal health concerns we believe that the ‘‘LuftiBus’’ popula-
tion can be considered a ‘‘large group of volunteers’’ representa-
tive of the Zurich population. First, in the course of the 18 years
Figure 2. Comparison between the four health groups. The lung function parameter FEV1 is compared between the four health groups at
ages between 8–90 years old. For this comparison only men of 175 cm and women of 165 cm were included. The 5th quantile indicates the lower
limit of normal for each group. FEV1: forced expiratory volume in one second. The four health groups are: healthy/non-smoker, healthy/smoker, sick/
non-smoker and sick/smoker.
doi:10.1371/journal.pone.0052619.g002
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the ‘‘LuftiBus’’ visited each village of the Zurich County and a
similar proportion of the population of each village is represented
in the dataset. Second, the age distribution of the ‘‘LuftiBus’’
dataset is similar to the age distribution of the Swiss population
apart from an over representation of teenagers [15]. Third, when
the ‘‘LuftiBus’’ was leased by schools whole classrooms were tested
which allowed us to perform a sensitivity analysis between the
children being tested in a compulsory or a voluntary setting. No
significant difference was found. Lastly, we excluded all ‘‘sick’’ and
‘‘smoking’’ individuals from our ‘‘healthy/non-smoking’’ reference
values, thus reducing possible biases caused by health concerns.
Lung function has been shown to be influenced by various
factors such as cohort effect [1], ethnicity [28] or BMI [29]. As
only marginal differences were found when performing sensitivity
analysis we did not exclude individuals or years tested but rather
considered them as part of our ‘‘general representative’’ popula-
tion.
We developed spirometry reference equations spanning from
school age to old age for a Central European population. The
equations were derived from a large general population and are
intended for every day clinical use as they can be implemented in
most clinical settings. Additionally they allow clinicians to choose
reference values depending on a given clinical situation.
Supporting Information
Supporting Information S1 Results S1; Quantile Regres-
sion reference equation and comparison with GAMLSS.
(DOC)
Table S1 Quantile regression reference equation.
(DOCX)
Figure S1 Residual plots for FEV1 from the GAMLSS
model. Residuals of FEV1 from the GAMLSS model using
BCPT are shown: (a) against fitted values of m (b) against each
person (c) kernel density estimate (d) normal QQ plot. The Figures
show that the model is adequately fitted as the plots are
homogenous, compact, well centred around the zero in the
density estimate plot and only about 1484 individuals are not on
the QQ-line. GAMLSS: Generalized Additive Models for
Location, Scale and Shape. BCPE: Box-Cox power exponential
density distribution function. FEV1: forced expiratory volume in
one second. m: mean.
(TIF)
Figure S2 Worm plot of the residuals of the GAMLSS
reference equation for FEV1. The worm plot shows that the
model is well fitted at every age. The top bar shows the 20 age
ranges tested (displayed in steps from 6 to 99 years). The 20
corresponding 20 QQ plots (quantile-quantile plots) are probabil-
ity plots, which is a graphical method for comparing the residuals
of the GAMLSS model. They read from bottom left to top right
and correspond to the 20 age ranges. GAMLSS: Generalized
Additive Models for Location, Scale and Shape. FEV1: forced
expiratory volume in one second.
(TIF)
Figure S3 Formula for calculating quantiles. Formule
taken from Rigby RA, Stasinopoulos DM (2004) Smooth centile
curves for skew and kurtotic data modelled using the Box-Cox
power exponential distribution. Stat Med 23: 3053–3076.
(TIF)
Figure S4 Residual plots for FEV1 for quantile regres-
sion. Residuals from the quantile regression model for the 50th
and the 5th quantile are shown. (a) against fitted values of m (b)
against each person (c) kernel density estimate (d) normal QQ plot.
The residuals show a slight skewed distribution which is
accentuated in the 5th quantile. This can be seen by the plots
being less centred and less compact, having individuals at 24 but
non at +4 in the density estimate plot and having less individuals
on the QQ-line. FEV1: forced expiratory volume in one second. m:
mean.
(TIF)
Figure S5 Comparison between the GAMLSS and
Quantile Regression reference equations. The lung
function parameter FEV1 is compared between the GAMLSS
and the Quantile Regression model between the ages of 8–90
years old. For this comparison only healthy non-smoking men of
175 cm and women of 165 cm were included. The 5th quantile
indicates the lower limit of normal for each group. GAMLSS:
Generalized Additive Models for Location, Scale and Shape.
Quantreg: quantile regression.
(TIF)
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